OUR FOUNDING LEADERSHIP TEAM

Douglas Oliver, MSW

President

• Global award-winning patient advocate, speaker, presenter​
• Co-founder & Impact Investor, Regenerative Outcomes Foundation, SANA Holdings, Oliver Vision Trust​
• U.S. 21st Century Cures Act 2016​
• Contributor for The Hill, WSJ, FOX, BBC, People, Washington Post​

Anthony Oliva, PhD

Chief Scientific Officer

• Executive with 25+ years experience in life science​
• Expertise in clinical development, regulatory affairs & non-dilutive funding strategies​
• Leadership roles in cell therapy & regenerative medicine at Longeveron Inc. & American Cell Technology, LLC

​

Jeff Ervin, MBA

Co-Founder

• SEC-registered finance executive​
• Investor and capitalization strategist in healthcare equity ​
• Leadership roles as Founder, CEO,  CFO for several Nasdaq & NYSE-listed regenerative medicine companies​
• Board Member, Cingulate